These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34046332)

  • 1. Efficacy of Living Donor Liver Transplantation in Patients with Methylmalonic Acidemia.
    Jang JG; Oh SH; Kim YB; Kim SH; Yoo HW; Lee BH; Namgoong JM; Kim DY; Kim KH; Song GW; Moon DB; Hwang S; Lee SG; Kim KM
    Pediatr Gastroenterol Hepatol Nutr; 2021 May; 24(3):288-294. PubMed ID: 34046332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative characteristics and management of liver transplantation for isolated methylmalonic acidemia-the largest experience in China.
    Jiang YZ; Sun LY; Zhu ZJ; Wei L; Qu W; Zeng ZG; Liu Y; Tan YL; He EH; Xu RF; Zhang L; Wang J; Chen XJ
    Hepatobiliary Surg Nutr; 2019 Oct; 8(5):470-479. PubMed ID: 31673536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.
    Pillai NR; Stroup BM; Poliner A; Rossetti L; Rawls B; Shayota BJ; Soler-Alfonso C; Tunuguntala HP; Goss J; Craigen W; Scaglia F; Sutton VR; Himes RW; Burrage LC
    Mol Genet Metab; 2019 Dec; 128(4):431-443. PubMed ID: 31757659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.
    Gan K; Li Z; Bao S; Fang Y; Wang T; Jin L; Ma M; Deng L; Peng Y; Li N; Zeng Z; Huang H
    Transpl Immunol; 2021 Dec; 69():101476. PubMed ID: 34601097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current role of liver transplantation for methylmalonic acidemia: a review of the literature.
    Kasahara M; Horikawa R; Tagawa M; Uemoto S; Yokoyama S; Shibata Y; Kawano T; Kuroda T; Honna T; Tanaka K; Saeki M
    Pediatr Transplant; 2006 Dec; 10(8):943-7. PubMed ID: 17096763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in the prognosis and development of patients with methylmalonic acidemia after living donor liver transplant.
    Sakamoto R; Nakamura K; Kido J; Matsumoto S; Mitsubuchi H; Inomata Y; Endo F
    Pediatr Transplant; 2016 Dec; 20(8):1081-1086. PubMed ID: 27670840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups.
    Chu TH; Chien YH; Lin HY; Liao HC; Ho HJ; Lai CJ; Chiang CC; Lin NC; Yang CF; Hwu WL; Lee NC; Lin SP; Liu CS; Hu RH; Ho MC; Niu DM
    Orphanet J Rare Dis; 2019 Apr; 14(1):73. PubMed ID: 30940196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease.
    Brassier A; Boyer O; Valayannopoulos V; Ottolenghi C; Krug P; Cosson MA; Touati G; Arnoux JB; Barbier V; Bahi-Buisson N; Desguerre I; Charbit M; Benoist JF; Dupic L; Aigrain Y; Blanc T; Salomon R; Rabier D; Guest G; de Lonlay P; Niaudet P
    Mol Genet Metab; 2013; 110(1-2):106-10. PubMed ID: 23751327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does living donation have advantages over deceased donation in liver transplantation?
    Kaido T; Uemoto S
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1598-603. PubMed ID: 20880167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of methylmalonic acidemia by liver or combined liver-kidney transplantation.
    Niemi AK; Kim IK; Krueger CE; Cowan TM; Baugh N; Farrell R; Bonham CA; Concepcion W; Esquivel CO; Enns GM
    J Pediatr; 2015 Jun; 166(6):1455-61.e1. PubMed ID: 25771389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.
    Lerut J; Iesari S; Vandeplas G; Fabbrizio T; Ackenine K; Núñez MEI; Komuta M; Coubeau L; Ciccarelli O; Bonaccorsi-Riani E
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):412-422. PubMed ID: 31521538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of blood methylmalonic acid level in methylmalonic acidemia after liver transplantation.
    Chen PW; Hwu WL; Ho MC; Lee NC; Chien YH; Ni YH; Lee PH
    Pediatr Transplant; 2010 May; 14(3):337-41. PubMed ID: 19686300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of living donor liver transplantation for patients with methylmalonic acidemia.
    Morioka D; Kasahara M; Horikawa R; Yokoyama S; Fukuda A; Nakagawa A
    Am J Transplant; 2007 Dec; 7(12):2782-7. PubMed ID: 17908273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry.
    Kim JM; Kim DG; Kim J; Lee K; Lee KW; Ryu JH; Kim BW; Choi DL; You YK; Kim DS; Nah YW; Kang KJ; Cho JY; Hong G; Yu HC; Moon JI; Choi D; Hwang S; Kim MS
    Clin Mol Hepatol; 2021 Jul; 27(3):451-462. PubMed ID: 33525077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Value of Liver Transplantation for Methylmalonic Acidemia.
    Jiang YZ; Sun LY
    Front Pediatr; 2019; 7():87. PubMed ID: 30949461
    [No Abstract]   [Full Text] [Related]  

  • 17. Should We Exclude Live Donor Liver Transplantation for Liver Transplant Recipients Requiring Mechanical Ventilation and Intensive Care Unit Care?
    Goldaracena N; Spetzler VN; Sapisochin G; J E; Moritz K; Cattral MS; Greig PD; Lilly L; McGilvray ID; Levy GA; Ghanekar A; Renner EL; Grant DR; Selzner M; Selzner N
    Transplant Direct; 2015 Sep; 1(8):e30. PubMed ID: 27500230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of patients with hepatorenal syndrome after living donor liver transplantation.
    Lee JP; Kwon HY; Park JI; Yi NJ; Suh KS; Lee HW; Kim M; Oh YK; Lim CS; Kim YS
    Liver Transpl; 2012 Oct; 18(10):1237-44. PubMed ID: 22714872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.
    Terrault NA; Stravitz RT; Lok AS; Everson GT; Brown RS; Kulik LM; Olthoff KM; Saab S; Adeyi O; Argo CK; Everhart JE; Rodrigo del R;
    Hepatology; 2014 Apr; 59(4):1311-9. PubMed ID: 24677192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and long-term outcomes of early liver transplantation for pediatric methylmalonic acidemia patients.
    Lin NC; Tsai HL; Chen CY; Yeh YT; Lei HJ; Chou SC; Chung MH; Yang CF; Niu DM; Loong CC; Hsia CY; Liu CS
    Pediatr Transplant; 2022 Jun; 26(4):e14228. PubMed ID: 35037342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.